Cellular and molecular mechanisms of kidney fibrosis

Sonja Djudjaj1, Peter Boor2

  • 1Institute of Pathology, RWTH University of Aachen, Germany.

Insights

Renal fibrosis, a key process in chronic kidney disease (CKD), involves excessive matrix deposition that impairs kidney function. This review details fibrosis in different kidney compartments and discusses anti-fibrotic treatment challenges.

Area of Science:

  • Nephrology
  • Pathology
  • Translational Medicine

Background:

  • Renal fibrosis is the common endpoint of chronic kidney injury and a primary driver of chronic kidney disease (CKD).
  • CKD affects over 10% of the global population, with limited therapeutic options.
  • Fibrosis leads to organ failure through excessive extracellular matrix deposition, disrupting kidney parenchyma.

Purpose of the Study:

  • To review the diverse manifestations, cellular origins, and key mediators of renal fibrosis across different kidney compartments.
  • To analyze the challenges in translating anti-fibrotic therapies into clinical practice.
  • To propose solutions and future research directions for combating renal fibrosis.

Main Methods:

  • Comprehensive literature review of renal fibrosis.
  • Analysis of histological compartments affected by fibrosis: glomeruli, tubulointerstitium, and vasculature.
  • Discussion of cellular origins and pathogenic processes.
  • Evaluation of clinical translation challenges for anti-fibrotic treatments.

Main Results:

  • Fibrosis presents differently in glomeruli (glomerulosclerosis), tubulointerstitium (interstitial fibrosis), and vasculature (arteriosclerosis, perivascular fibrosis).
  • Emerging mediators and cellular processes driving fibrosis in each compartment are identified.
  • Significant hurdles exist in translating experimental anti-fibrotic strategies to effective clinical treatments.

Conclusions:

  • Understanding the specific mechanisms of fibrosis in each kidney compartment is crucial.
  • Overcoming clinical translation barriers is essential for developing effective anti-fibrotic therapies.
  • Future research should focus on targeted interventions and innovative therapeutic strategies for CKD.

Related Concept Videos

Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
891